Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy

BACKGROUND: The purpose of this study was set to investigate the prognostic role of plasmatic levels of heat shock protein 90 alpha (HSP90α) at diagnosis in advanced lung cancer patients treated with Programmed cell death protein 1 (PD-1)/Programmed cell death-Ligand protein 1 (PD-L1) inhibitors plu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shubin, Yu, Qitao, Zhou, Shaozhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678125/
https://www.ncbi.nlm.nih.gov/pubmed/34926266
http://dx.doi.org/10.3389/fonc.2021.765115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678125/
https://www.ncbi.nlm.nih.gov/pubmed/34926266
http://dx.doi.org/10.3389/fonc.2021.765115

Ejemplares similares